| ADMET | Absortion, Distribution, Metabolism, Excretion and Toxicity |
| AML | Acute Myeloid Leukemia |
| AMP | Antimicrobial Peptide |
| BTC | Bicycle Toxin Conjugate |
| CME | Clathrin-Mediated Endocytosis |
| CPP | Cell-Penetrating Peptide |
| cCPP | Cationic Cell-Penetrating Peptide |
| CvME | Caveolae-Mediated Endocytosis |
| DPV | Diatos Peptide Vector |
| ELP | Elastin-Like Polypeptide |
| EN1 | Engrailed 1 |
| ER+ | Estrogen Receptor-Positive |
| FRET | Fluorescence Resonance Energy Transfer |
| GAG | Glycosaminoglican |
| GEP-NET | Gastroenteropancreatic Neuroendocrine Tumor |
| GPCR | G Protein-Coupled Receptor |
| HS | Heparan Sulfate |
| HTH | Helix-turn-helix |
| iPep | Interfering Peptide |
| MAP | Model Amphipathic Peptide |
| MDR | Multidrug Resistance |
| MMP | Matrix Metalloproteinase |
| MT1-MMP | Membrane Type 1 Matrix Metalloproteinase |
| NET | Neuroendocrine Tumor |
| OSCC | Oral Squamous Cell Carcinoma |
| PAR1 | Protease-Activated Receptor 1 |
| PCNA | Proliferating Cell Nuclear Antigen |
| PDX | Patient-Derived Xenograft |
| PGE2 | Prostaglandin E2 |
| PNA | Peptide Nucleic Acid |
| PP2A | Protein Phosphatase 2A |
| PRRT | Peptide Receptor Radionuclide Therapy |
| PS | Phosphatidylserine |
| ROS | Reactive Oxygen Species |
| saCPP | Secondary Amphipathic Cell-Penetrating Peptide |
| SAR | Structure-Activity Relationship |
| SSTR2 | Type 2 Somatostatin Receptor |
| TAM | Tumor-Associated Macrophage |
| TNBC | Triple-Negative Breast Cancer |
| WT | Wild-Type |